Literature DB >> 4885677

Appraisal of the extrapancreatic actions of sulfonylureas.

J M Feldman, H E Lebovitz.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4885677

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


× No keyword cloud information.
  26 in total

1.  An in vitro model for screening oral hypoglycemics.

Authors:  R R Bhonde; P B Parab; V S Sheorin
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999 Jul-Aug       Impact factor: 2.416

2.  Do insulinotropic glucose-lowering drugs do more harm than good? The hypersecretion hypothesis revisited.

Authors:  I Rustenbeck; S Baltrusch; M Tiedge
Journal:  Diabetologia       Date:  2010-07-01       Impact factor: 10.122

Review 3.  Insulin and oral hypoglycaemic agents. I. Physiological and clinical pharmacological aspects.

Authors:  H D Breidahl; G C Ennis; F I Martin; J R Stawell; P Taft
Journal:  Drugs       Date:  1972       Impact factor: 9.546

4.  The effect of glibenclamide on two enzymes important in gluconeogenesis.

Authors:  J M Foy; V F Standing
Journal:  Br J Pharmacol       Date:  1973-06       Impact factor: 8.739

5.  Studies on the site of action of tolbutamide in the lipolytic system.

Authors:  C Rosak; K M Bartelt; J Beyer; K Schöffling
Journal:  Diabetologia       Date:  1972-07       Impact factor: 10.122

6.  Influence of sulfonylureas on the secretion, disposal and effect of insulin.

Authors:  L O Almér; E Johansson; A Melander; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

7.  Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients.

Authors:  A J Scheen; P J Lefebvre; A S Luyckx
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Effects of long-term feeding of glibenclamide on normal rats.

Authors:  A V George; K T Augusti
Journal:  Experientia       Date:  1976

9.  Trial of sulfonylurea in combination with insulin in the therapy of diabetes type I and II. Evidence against a primary extrapancreatic receptor effect.

Authors:  W P Bieger; R Dlugosch; A Rettenmeier; H D Holler; H Bert; W Schwarz; W Fiehn; J Merkt; H Weicker
Journal:  Klin Wochenschr       Date:  1984-07-02

10.  Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes.

Authors:  K P Ratzmann; B Schulz; P Heinke; W Besch
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.